Hiroshi Koike

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 4

Top Topics

Recombinant Human

Patient Reported Outcomes

Top Venues

International journal of molecular sciences

Journal of clinical medicine

Japanese journal of clinical oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Jiarui Zhang, Yoshihiro Nishida, Hiroshi Koike, Lisheng Zhuo, Kan Ito, Kunihiro Ikuta, Tomohisa Sakai, Shiro Imagama
Development of Therapeutic Agent for Osteoarthritis via Inhibition of KIAA1199 Activity: Effect of Ipriflavone In Vivo. International journal of molecular sciences 24 (15) (2023)
Kunihiro Ikuta, Yoshihiro Nishida, Tomohisa Sakai, Hiroshi Koike, Kan Ito, Hiroshi Urakawa, Shiro Imagama
Surgical Treatment and Complications of Deep-Seated Nodular Plexiform Neurofibromas Associated with Neurofibromatosis Type 1. Journal of clinical medicine 11 (19) (2022)
Hiroshi Koike, Yoshihiro Nishida, Tamayuki Shinomura, Bisei Ohkawara, Kinji Ohno, Lisheng Zhuo, Koji Kimata, Takahiro Ushida, Shiro Imagama
Possible Repositioning of an Oral Anti-Osteoporotic Drug, Ipriflavone, for Treatment of Inflammatory Arthritis via Inhibitory Activity of KIAA1199, a Novel Potent Hyaluronidase. International journal of molecular sciences 23 (8) (2022)
Tomohito Hagi, Tomoki Nakamura, Akihito Nagano, Hiroshi Koike, Kenji Yamada, Hisaki Aiba, Nasa Fujihara, Junji Wasa, Kunihiro Asanuma, Eiji Kozawa, Daisuke Ishimura, Katsuhisa Kawanami, Yuya Izubuchi, Yoji Shido, Akihiro Sudo, Yoshihiro Nishida
Clinical outcome in patients who underwent amputation due to extremity soft tissue sarcoma: Tokai Musculoskeletal Oncology Consortium study. Japanese journal of clinical oncology (2021)